Updated Date: Mon, 30 Dec 2024 00:00:00 EST
Vous n'êtes pas connecté
THURSDAY, Jan. 2, 2025 -- The U.S. Food and Drug Administration has approved Symvess, the first acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is...
Updated Date: Mon, 30 Dec 2024 00:00:00 EST
Updated Date: Mon, 30 Dec 2024 00:00:00 EST
FRIDAY, Jan. 3, 2025 -- The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for...
FRIDAY, Jan. 3, 2025 -- The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for...
THURSDAY, Jan. 2, 2025 -- Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB)...
FDA Approves Zepbound as the First Prescription Drug for Obstructive Sleep Apnea in Adults with Obesity On December 20, 2024, the U.S. Food and Drug...
The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug specifically for treating...
TUESDAY, Jan. 7, 2025 -- The U.S. Food and Drug Administration released draft guidelines on Jan. 6 proposing that manufacturers conduct larger, more...
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has...
TUESDAY, Jan. 7, 2025 -- The first-ever U.S. Food and Drug Administration guidelines on lead in baby food are under fire from health experts who argue...